I appreciate the explanation, because previous witnesses were trying to compare apples to apples, but I realize after your testimony that really we're looking at apples to oranges, because the entire system is different, and we really have to take a close look at this when we're discussing national pharmacare.
Mr. Dempster, I'm sorry I interrupted you, but could you add to my question?